These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33278788)

  • 1. Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL.
    Qian XH; Liu XY; Zhu ZY; Wang SG; Song XX; Chen G; Wu JY; Tang HD; Cao L
    Seizure; 2021 Jan; 84():47-52. PubMed ID: 33278788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
    Tran Mau-Them F; Guibaud L; Duplomb L; Keren B; Lindstrom K; Marey I; Mochel F; van den Boogaard MJ; Oegema R; Nava C; Masurel A; Jouan T; Jansen FE; Au M; Chen AH; Cho M; Duffourd Y; Lozier E; Konovalov F; Sharkov A; Korostelev S; Urteaga B; Dickson P; Vera M; Martínez-Agosto JA; Begemann A; Zweier M; Schmitt-Mechelke T; Rauch A; Philippe C; van Gassen K; Nelson S; Graham JM; Friedman J; Faivre L; Lin HJ; Thauvin-Robinet C; Vitobello A
    Genet Med; 2019 Apr; 21(4):1008-1014. PubMed ID: 30166628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation.
    Chen PS; Chen YF; Chiu JY; Wu MC; Tai CH; Chang YY; Lan MY; Lee NC; Lin CH
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1557-1566. PubMed ID: 38650104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo variants of IRF2BPL result in developmental epileptic disorder.
    Wang Y; Ke Z; Li Y; Qiu M; Liu J; Yang Z; Wen S; Liang M; Chen S
    Orphanet J Rare Dis; 2024 Mar; 19(1):121. PubMed ID: 38481258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
    Gardella E; Michelucci R; Christensen HM; Fenger CD; Reale C; Riguzzi P; Pasini E; Albini-Riccioli L; Papa V; Foschini MP; Cenacchi G; Furia F; Marjanovic D; Hammer TB; Møller RS; Rubboli G
    Epilepsia; 2023 Aug; 64(8):e170-e176. PubMed ID: 37114479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF2BPL: A new genotype for progressive myoclonus epilepsies.
    Costa C; Oliver KL; Calvello C; Cameron JM; Imperatore V; Tonelli L; Colavito D; Franceschetti S; Canafoglia L; Berkovic SF; Prontera P
    Epilepsia; 2023 Aug; 64(8):e164-e169. PubMed ID: 36810721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel IRF2BPL truncating variant is associated with endolysosomal storage.
    Ginevrino M; Battini R; Nuovo S; Simonati A; Micalizzi A; Contaldo I; Serpieri V; Valente EM
    Mol Biol Rep; 2020 Jan; 47(1):711-714. PubMed ID: 31583567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype?
    Skorvanek M; Dusek P; Rydzanicz M; Walczak A; Kosinska J; Kostrzewa G; Brzozowska M; Han V; Dosekova P; Gdovinova Z; Lehotska Z; Lisowski P; Ploski R
    Parkinsonism Relat Disord; 2019 May; 62():239-241. PubMed ID: 30733140
    [No Abstract]   [Full Text] [Related]  

  • 9. IRF2BPL gene variants with dystonia: one new Chinese case report.
    Yang F; Li H; Dai Y; Zhang R; Zhang JT
    BMC Neurol; 2023 Jan; 23(1):32. PubMed ID: 36670390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRF2BPL gene mutation: Expanding on neurologic phenotypes.
    Shelkowitz E; Singh JK; Larson A; Elias ER
    Am J Med Genet A; 2019 Nov; 179(11):2263-2271. PubMed ID: 31432588
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Heide S; Davoine CS; Cunha P; Scherer-Gagou C; Keren B; Stevanin G; Charles P; Heron D; Brice A; Durr A
    Neurol Genet; 2023 Dec; 9(6):e200096. PubMed ID: 38235039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF2BPL-Related Disorder, Causing Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and Seizures (NEDAMSS) Is Characterized by Pathology Consistent with DRPLA.
    Venkateswaran S; Michaud J; Ito Y; Geraghty M; Lewis EC; Ellezam B; Boycott KM; Dyment DA; Kernohan KD;
    Mov Disord; 2024 Nov; 39(11):2102-2109. PubMed ID: 39224955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel de novo FEM1C variant is linked to neurodevelopmental disorder with absent speech, pyramidal signs and limb ataxia.
    Dubey AA; Krygier M; Szulc NA; Rutkowska K; Kosińska J; Pollak A; Rydzanicz M; Kmieć T; Mazurkiewicz-Bełdzińska M; Pokrzywa W; Płoski R
    Hum Mol Genet; 2023 Mar; 32(7):1152-1161. PubMed ID: 36336956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel truncating variant of MN1 penultimate exon identified in a Chinese patient with newly recognized MN1 C-terminal truncation syndrome: Case report and literature review.
    Zhao A; Shu D; Zhang D; Yang B; Hong L; Wang A; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Gu Q
    Int J Dev Neurosci; 2022 Feb; 82(1):96-103. PubMed ID: 34708882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult onset familiar dystonia-plus syndrome: A novel presentation of IRF2BPL-associated neurodegeneration.
    Antonelli F; Grieco G; Cavallieri F; Casella A; Valente EM
    Parkinsonism Relat Disord; 2022 Jan; 94():22-24. PubMed ID: 34864472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of epilepsy in children with IRF2BPL gene variation].
    Niu Q; Yang Y; Niu XY; Chen Y; Liu WW; Zhang YH
    Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):506-510. PubMed ID: 34102826
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature.
    Pisano S; Melis M; Figorilli M; Polizzi L; Rocchi L; Giglio S; Defazio G; Muroni A
    Seizure; 2022 Jul; 99():12-15. PubMed ID: 35525099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of a novel de novo variant of CSNK2A1 gene in a boy with Okur-Chung neurodevelopmental syndrome].
    Wu R; Tang W; Liang L; Li X; Ouyang N; Meng Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jun; 37(6):641-644. PubMed ID: 32472542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nonsense variant in EXOC8 underlies a neurodevelopmental disorder.
    Ullah A; Krishin J; Haider N; Aurangzeb B; Abdullah ; Suleman S; Ahmad W; Hansen T; Basit S
    Neurogenetics; 2022 Jul; 23(3):203-212. PubMed ID: 35460391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.
    Qiao F; Wang C; Luo C; Wang Y; Shao B; Tan J; Hu P; Xu Z
    Mol Genet Genomic Med; 2019 Sep; 7(9):e897. PubMed ID: 31347296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.